+30 YEARS' GLOBAL EXPERIENCE
ACROSS MULTIPLE INDICATIONS1-4
UROLOGY
BOTOX® is indicated for the management of bladder dysfunctions in adult patients who are not adequately managed with anticholinergics: overactive bladder with symptoms of urinary incontinence, urgency and frequency; neurogenic detrusor overactivity with urinary incontinence due to subcervical spinal cord injury (traumatic or non-traumatic), or multiple sclerosis.5
+30 YEARS' GLOBAL EXPERIENCE ACROSS MULTIPLE INDICATIONS1-4
UROLOGY
BOTOX® is indicated for the management of bladder dysfunctions in adult patients who are not adequately managed with anticholinergics: overactive bladder with symptoms of urinary incontinence, urgency and frequency; neurogenic detrusor overactivity with urinary incontinence due to subcervical spinal cord injury (traumatic or non-traumatic), or multiple sclerosis.5
Your vision will describe how the service can improve the quality of care and outcomes for patients with overactive bladder (OAB) or neurogenic detrusor overactivity (NDO). It may also describe what you intend your service to look like in 3–5 years’ time and how your service will help to address any gaps or challenges in the local health environment.
Engagement with key stakeholders involved in the care of patients with OAB or NDO will be essential to shape the vision and planning of your service.
Incorporate intermediate steps towards your goal
Advantages of the nurse playing a key role, include:
Nurse specialists are motivated and keen to take on the new role
It can allow consultant time to be dedicated to emergency care
Nurse-led outpatient clinics can result in improved waiting times for patients, improved quality of life and better patient satisfaction
For further information and examples of good clinical practice in line with GIRFT guidance, please request support via the Contact Us page.
Other considerations in order to achieve your vision for your BOTOX® urology service:
Operational considerations such as:
The procedure itself
Equipment
Staff and training
Available facilities
Patient scheduling
Creating a patient-centric service: through the provision of pre- and post-procedure patient education and follow-up
Securing funding: Gaining financial support for your service is a critical part of the planning process. It is important to:
develop a business case
estimate the service income
identify and engage with the right stakeholders
GIRFT: Getting It Right First Time; NDO: neurogenic detrusor overactivity; OAB: overactive bladder.
Please refer to the BOTOX® Summary of Product Characteristics for further information on adverse events, contraindications and special warnings and precautions for use.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/
Adverse events should also be reported to AbbVie on GBPV@abbvie.com
Date of preparation: April 2024. UK-BUO-240009.
